Trial intelligence / Profile preview

Intranasal dexmedetomidine doses to prevent catheter-related bladder discomfort in gynecological surgery

ChiCTR2100048657Phase 4Recruiting

Sponsor
West China Second University Hospital
Start
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in cystitis (4 arms), sponsored by West China Second University Hospital. Primary endpoint: Catheter-related bladder irritation score. Started Jun 2023; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

cystitis

Beyond the preview

Go deeper on ChiCTR2100048657.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100048657.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call